Activation and evasion of innate antiviral immunity by herpes simplex virus
about
Herpes simplex virus serotype and entry receptor availability alter CNS disease in a mouse model of neonatal HSVDifferential reliance on autophagy for protection from HSV encephalitis between newborns and adultsThe immunologic basis for severe neonatal herpes disease and potential strategies for therapeutic intervention.Complement Opsonization Promotes Herpes Simplex Virus 2 Infection of Human Dendritic Cells.Use of transcriptional profiling to delineate the initial response of mice to intravaginal herpes simplex virus type 2 infection.Dendritic cells, macrophages, NK and CD8+ T lymphocytes play pivotal roles in controlling HSV-1 in the trigeminal ganglia by producing IL1-beta, iNOS and granzyme B.Polyprenyl Immunostimulant in Feline Rhinotracheitis: Randomized Placebo-Controlled Experimental and Field Safety Studies.Early events in herpes simplex virus lifecycle with implications for an infection of lifetimePreclinical Mouse Models for Analysis of the Therapeutic Potential of Engineered Oncolytic Herpes VirusesInnate responses to small interfering RNA pools inhibiting herpes simplex virus infection in astrocytoid and epithelial cells.Antiviral Action of Hydromethanolic Extract of Geopropolis from Scaptotrigona postica against Antiherpes Simplex Virus (HSV-1)Discovery of a new antiviral protein isolated Lonomia obliqua analysed by bioinformatics and real-time approachesHSV-1-induced chemokine expression via IFI16-dependent and IFI16-independent pathways in human monocyte-derived macrophages.Tunneling Nanotubes as a Novel Route of Cell-to-Cell Spread of Herpesviruses.Abortigenic but Not Neurotropic Equine Herpes Virus 1 Modulates the Interferon Antiviral Defense
P2860
Q34517114-1EECF103-5A50-453E-950E-9F77B15026C4Q34876304-91A1DBC9-A1A3-4A9A-9896-BDEAE7551BA1Q36765590-36DC214B-E0B0-4ED5-B240-1BBD2B598DA3Q36878921-00EAA8C1-48AF-4BC2-94D1-4E22965F7C38Q36913153-22EC49DE-F114-48E0-A43A-D0F06B665140Q37658413-4D7E1D8B-E7E0-470E-A6E4-93391C446874Q37667299-A7954B19-CB14-4200-9BBB-B7C4B4EE6E99Q37980142-04D7470F-E711-42C4-9A25-2A23958C8AB7Q38795324-97E07354-26DE-43D7-A552-36940CC855E4Q38977911-9FCEF453-8757-4404-9AC4-C9CB5092D1BEQ42110851-BF335F9D-5402-43EF-BBA9-A6E32D8E2FB1Q42113134-57815E14-429A-4323-BF3B-F548B8E27FD7Q42412053-7D6CC285-2A77-4F19-845B-68CEF4B5924BQ52680798-019D8F09-AAA5-4C8C-B333-18879E764379Q58746172-1B7CE483-D2AE-4E18-85C2-2F4A0AE6379F
P2860
Activation and evasion of innate antiviral immunity by herpes simplex virus
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Activation and evasion of innate antiviral immunity by herpes simplex virus
@ast
Activation and evasion of innate antiviral immunity by herpes simplex virus
@en
type
label
Activation and evasion of innate antiviral immunity by herpes simplex virus
@ast
Activation and evasion of innate antiviral immunity by herpes simplex virus
@en
prefLabel
Activation and evasion of innate antiviral immunity by herpes simplex virus
@ast
Activation and evasion of innate antiviral immunity by herpes simplex virus
@en
P2093
P2860
P356
P1433
P1476
Activation and evasion of innate antiviral immunity by herpes simplex virus
@en
P2093
Jesper Melchjorsen
Sampsa Matikainen
Søren R Paludan
P2860
P304
P356
10.3390/V1030737
P577
2009-11-05T00:00:00Z